Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway.

Cheleschi S, Gallo I, Barbarino M, Giannotti S, Mondanelli N, Giordano A, Tenti S, Fioravanti A.

Int J Mol Sci. 2019 Oct 20;20(20). pii: E5200. doi: 10.3390/ijms20205200.

2.

MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes.

Cheleschi S, Tenti S, Mondanelli N, Corallo C, Barbarino M, Giannotti S, Gallo I, Giordano A, Fioravanti A.

Cells. 2019 Aug 11;8(8). pii: E874. doi: 10.3390/cells8080874.

3.

Nanoparticle-biomolecular corona: A new approach for the early detection of non-small-cell lung cancer.

Di Domenico M, Pozzi D, Palchetti S, Digiacomo L, Iorio R, Astarita C, Fiorelli A, Pierdiluca M, Santini M, Barbarino M, Giordano A, Di Carlo A, Frati L, Mahmoudi M, Caracciolo G.

J Cell Physiol. 2019 Jun;234(6):9378-9386. doi: 10.1002/jcp.27622. Epub 2018 Dec 5.

PMID:
30520022
4.

Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration.

Tosi GM, Neri G, Caldi E, Fusco F, Bacci T, Tarantello A, Nuti E, Marigliani D, Baiocchi S, Traversi C, Barbarino M, Eandi CM, Parolini B, Mundo L, Santucci A, Orlandini M, Galvagni F.

Sci Rep. 2018 Jun 29;8(1):10141. doi: 10.1038/s41598-018-28203-5.

5.

TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration.

Tosi GM, Neri G, Caldi E, Fusco F, Bacci T, Tarantello A, Nuti E, Marigliani D, Baiocchi S, Traversi C, Barbarino M, Eandi CM, Parolini B, Mundo L, Santucci A, Orlandini M, Galvagni F.

Sci Rep. 2018 May 23;8(1):8053. doi: 10.1038/s41598-018-26442-0. Erratum in: Sci Rep. 2018 Jun 29;8(1):10141.

6.

Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.

Barbarino M, Cesari D, Intruglio R, Indovina P, Namagerdi A, Bertolino FM, Bottaro M, Rahmani D, Bellan C, Giordano A.

J Cell Physiol. 2018 Sep;233(9):7391-7401. doi: 10.1002/jcp.26579. Epub 2018 Apr 16.

PMID:
29659015
7.

Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells.

Damiano S, Montagnaro S, Puzio MV, Severino L, Pagnini U, Barbarino M, Cesari D, Giordano A, Florio S, Ciarcia R.

J Cell Biochem. 2018 Jun;119(6):4845-4854. doi: 10.1002/jcb.26686. Epub 2018 Mar 1.

PMID:
29345355
8.

Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.

Pastina P, Nardone V, Croci S, Battaglia G, Vanni F, Bellan C, Barbarino M, Ricci V, Costantini S, Capone F, Botta C, Zarone MR, Misso G, Boccellino M, Caraglia M, Giordano A, Paladini P, Tassone P, Tagliaferri P, Cusi MG, Pirtoli L, Correale P.

J Thorac Dis. 2017 Sep;9(9):3123-3131. doi: 10.21037/jtd.2017.08.68.

9.

Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs.

Cimini A, d'Angelo M, Benedetti E, D'Angelo B, Laurenti G, Antonosante A, Cristiano L, Di Mambro A, Barbarino M, Castelli V, Cinque B, Cifone MG, Ippoliti R, Pentimalli F, Giordano A.

J Cell Physiol. 2017 Feb;232(2):312-322. doi: 10.1002/jcp.25421. Epub 2016 Jun 2.

PMID:
27171480
10.

ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors.

Giannini G, Vesci L, Battistuzzi G, Vignola D, Milazzo FM, Guglielmi MB, Barbarino M, Santaniello M, Fantò N, Mor M, Rivara S, Pala D, Taddei M, Pisano C, Cabri W.

J Med Chem. 2014 Oct 23;57(20):8358-77. doi: 10.1021/jm5008209. Epub 2014 Oct 8.

PMID:
25233084
11.

Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.

Taddei M, Ferrini S, Giannotti L, Corsi M, Manetti F, Giannini G, Vesci L, Milazzo FM, Alloatti D, Guglielmi MB, Castorina M, Cervoni ML, Barbarino M, Foderà R, Carollo V, Pisano C, Armaroli S, Cabri W.

J Med Chem. 2014 Mar 27;57(6):2258-74. doi: 10.1021/jm401536b. Epub 2014 Mar 17.

PMID:
24588105
12.

Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold.

Giannini G, Battistuzzi G, Vesci L, Milazzo FM, De Paolis F, Barbarino M, Guglielmi MB, Carollo V, Gallo G, Artali R, Dallavalle S.

Bioorg Med Chem Lett. 2014 Jan 15;24(2):462-6. doi: 10.1016/j.bmcl.2013.12.048. Epub 2013 Dec 18.

13.

Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.

Bargiotti A, Musso L, Dallavalle S, Merlini L, Gallo G, Ciacci A, Giannini G, Cabri W, Penco S, Vesci L, Castorina M, Milazzo FM, Cervoni ML, Barbarino M, Pisano C, Giommarelli C, Zuco V, De Cesare M, Zunino F.

Eur J Med Chem. 2012 Jul;53:64-75. doi: 10.1016/j.ejmech.2012.03.036. Epub 2012 Mar 28.

PMID:
22538015
14.

Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90.

Baruchello R, Simoni D, Grisolia G, Barbato G, Marchetti P, Rondanin R, Mangiola S, Giannini G, Brunetti T, Alloatti D, Gallo G, Ciacci A, Vesci L, Castorina M, Milazzo FM, Cervoni ML, Guglielmi MB, Barbarino M, Foderà R, Pisano C, Cabri W.

J Med Chem. 2011 Dec 22;54(24):8592-604. doi: 10.1021/jm201155e. Epub 2011 Nov 23.

PMID:
22066525
15.

Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry.

Badaloni E, Barbarino M, Cabri W, D'Acquarica I, Forte M, Gasparrini F, Giorgi F, Pierini M, Simone P, Ursini O, Villani C.

J Chromatogr A. 2011 Jun 24;1218(25):3862-75. doi: 10.1016/j.chroma.2011.04.048. Epub 2011 Apr 27. Erratum in: J Chromatogr A. 2011 Dec 9;1218(49):8974.

PMID:
21561626
16.

Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine.

Pisano C, Vesci L, Milazzo FM, Guglielmi MB, Foderà R, Barbarino M, D'Incalci M, Zucchetti M, Petrangolini G, Tortoreto M, Perego P, Zuco V, Orlandi A, Passeri D, Carminati P, Cavazza C, Zunino F.

Clin Cancer Res. 2010 Aug 1;16(15):3944-53. doi: 10.1158/1078-0432.CCR-10-0964. Epub 2010 Jun 18.

17.

Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.

Dallavalle S, Cincinelli R, Nannei R, Merlini L, Morini G, Penco S, Pisano C, Vesci L, Barbarino M, Zuco V, De Cesare M, Zunino F.

Eur J Med Chem. 2009 May;44(5):1900-12. doi: 10.1016/j.ejmech.2008.11.005. Epub 2008 Nov 19.

PMID:
19084294
18.

Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.

Hanessian S, Auzzas L, Giannini G, Marzi M, Cabri W, Barbarino M, Vesci L, Pisano C.

Bioorg Med Chem Lett. 2007 Nov 15;17(22):6261-5. Epub 2007 Sep 8.

PMID:
17892933
19.

Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response.

Zuco V, Zanchi C, Lanzi C, Beretta GL, Supino R, Pisano C, Barbarino M, Zanier R, Bucci F, Aulicino C, Carminati P, Zunino F.

Neoplasia. 2005 Jul;7(7):667-77.

20.

Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.

Stano P, Bufali S, Pisano C, Bucci F, Barbarino M, Santaniello M, Carminati P, Luisi PL.

J Liposome Res. 2004;14(1-2):87-109.

PMID:
15461935

Supplemental Content

Loading ...
Support Center